Inhibrx Current Ratio from 2010 to 2024

INBX Stock  USD 14.08  0.10  0.72%   
Inhibrx Current Ratio yearly trend continues to be fairly stable with very little volatility. Current Ratio will likely drop to 3.26 in 2024. Current Ratio is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. View All Fundamentals
 
Current Ratio  
First Reported
2010-12-31
Previous Quarter
5.2450277
Current Value
3.26
Quarterly Volatility
2.30064761
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Interest Expense of 33.4 M, Minority Interest of 0.0 or Tax Provision of 2.6 K, as well as many indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0021 or PTB Ratio of 43.23. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.
  
Check out the analysis of Inhibrx Correlation against competitors.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Latest Inhibrx's Current Ratio Growth Pattern

Below is the plot of the Current Ratio of Inhibrx over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. Inhibrx's Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 7.51 X10 Years Trend
Pretty Stable
   Current Ratio   
       Timeline  

Inhibrx Current Ratio Regression Statistics

Arithmetic Mean3.93
Geometric Mean3.13
Coefficient Of Variation58.52
Mean Deviation1.35
Median3.87
Standard Deviation2.30
Sample Variance5.29
Range9.822
R-Value0.25
Mean Square Error5.34
R-Squared0.06
Significance0.37
Slope0.13
Total Sum of Squares74.10

Inhibrx Current Ratio History

2024 3.26
2023 5.25
2022 10.17
2021 6.2
2020 4.21
2019 0.76
2018 0.35

About Inhibrx Financial Statements

Inhibrx investors use historical fundamental indicators, such as Inhibrx's Current Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Ratio 5.25  3.26 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.